The total number of shares to be listed and traded is 301,257,000 shares, and the listing and trading date is October 19, 2026.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Announcement on Listing and Trading of Certain Restricted Shares from the Initial Public Offering
Filed with SSE · Stock code 603193 · · 5 pages · Chinese
Summary by 6ix AI
Runben Biotechnology Co Ltd. announced the listing and trading of certain restricted shares from its initial public offering. The filing details the number of shares that will become tradable and the commitments made by shareholders regarding these shares. It also includes verification opinions from intermediaries confirming compliance with relevant regulations. The restricted shares will be available for trading starting on a specified date, following the expiration of their lock-up period.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Runben Biotechnology Co Ltd. on 6ix
Story so far
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Earlier from Runben Biotechnology
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Profit Distribution Plan for the First Half of 2026
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
Later from Runben Biotechnology
- (603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Announcement on Key Operating Data for Q3 2026
- (603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Announcement on Resolutions of the 14th Meeting of the 2nd Board of Directors
- (603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Announcement on Use of Certain Temporarily Idle Raised Funds for Cash Management
- (603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Report for Q3 2026
Follow Runben Biotechnology into a list and get an email when it puts out news.
Follow Runben Biotechnology